Biomarker Testing: Improving Access to Improve Care (TX)

8/25/22, 3:00 PM
America/New York GMT -4 summer


Cancer has proven to be a major burden for the Hispanic community, which accounts for nearly 20% of America's population. In fact, the leading cause of death for Hispanic Americans is cancer; one in three Hispanics will be diagnosed with cancer in their lifetime. Despite being at a higher risk for certain cancer types, Hispanic Americans, as compared to their non-Hispanic White counterparts, are underdiagnosed for the most common cancers. Knowing this information, NHMA and Amgen Inc. have partnered to develop a webinar series to educate the public on the impact of cancer on Hispanic Americans and disparities in cancer care and outcomes. In this webinar, we will be joined by Dr. Rodriguez who is board certified in medical oncology and hematology. She has a special interest in the early detection of lung cancer and developing programs to eradicate healthcare disparities. Join us in this discussion!

Moderator: Dr. Elena Rios
President & CEO
National Hispanic Medical Association

Estelamari Rodriguez, MD, MPH
Associate Director of Community Outreach
Co-Lead of the Thoracic Site Disease Group
NCI-designated Sylvester Comprehensive
Cancer Center at the University of Miami Miller School of Medicine

Time: 12:00 p.m. ET

Previous registration necessary?


Simultaneous translation ?


Will it be recorded?

Elena Rios

Biomarker Testing: Improving Access to Improve Care (TX)




Estelamari Rodriguez


Link to the Event

Banner to the Event

Biomarker Testing: Improving Access to Improve Care (TX)